Han W - Search Results

1

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling.

Matissek SJ, Karbalivand M, Han W, Boutilier A, Yzar-Garcia E, Kehoe LL, Gardner DS, Hage A, Fleck K, Jeffers V, Rajsbaum R, Elsawa SF. Matissek SJ, et al. Among authors: han w. Oncotarget. 2022 Aug 3;13:944-959. doi: 10.18632/oncotarget.28261. eCollection 2022. Oncotarget. 2022. PMID: 35937499 Free PMC article.

2

Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.

Jackson DA, Smith TD, Amarsaikhan N, Han W, Neil MS, Boi SK, Vrabel AM, Tolosa EJ, Almada LL, Fernandez-Zapico ME, Elsawa SF. Jackson DA, et al. Among authors: han w. J Immunol. 2015 Sep 15;195(6):2908-16. doi: 10.4049/jimmunol.1402974. Epub 2015 Aug 3. J Immunol. 2015. PMID: 26238488 Free PMC article.

3

Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2.

Han W, Jackson DA, Matissek SJ, Misurelli JA, Neil MS, Sklavanitis B, Amarsaikhan N, Elsawa SF. Han W, et al. J Immunol. 2017 Jun 1;198(11):4481-4489. doi: 10.4049/jimmunol.1601490. Epub 2017 May 1. J Immunol. 2017. PMID: 28461568 Free PMC article.

4

Elevated GLI3 expression in germinal center diffuse large B cell lymphoma.

Han W, Ibarra G, Gupta M, Yin Y, Elsawa SF. Han W, et al. Leuk Lymphoma. 2018 Nov;59(11):2743-2745. doi: 10.1080/10428194.2018.1439169. Epub 2018 Feb 21. Leuk Lymphoma. 2018. PMID: 29465267 No abstract available.

5

Bone marrow stromal cells interaction with titanium; Effects of composition and surface modification.

Duvvuru MK, Han W, Chowdhury PR, Vahabzadeh S, Sciammarella F, Elsawa SF. Duvvuru MK, et al. Among authors: han w. PLoS One. 2019 May 22;14(5):e0216087. doi: 10.1371/journal.pone.0216087. eCollection 2019. PLoS One. 2019. PMID: 31116747 Free PMC article.

6

Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia.

Han W, Matissek SJ, Jackson DA, Sklavanitis B, Elsawa SF. Han W, et al. Oncotarget. 2019 May 21;10(36):3400-3407. doi: 10.18632/oncotarget.26946. eCollection 2019 May 21. Oncotarget. 2019. PMID: 31164961 Free PMC article.

7

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors.

Li W, Gupta SK, Han W, Kundson RA, Nelson S, Knutson D, Greipp PT, Elsawa SF, Sotomayor EM, Gupta M. Li W, et al. Among authors: han w. J Hematol Oncol. 2019 Jul 9;12(1):73. doi: 10.1186/s13045-019-0761-2. J Hematol Oncol. 2019. PMID: 31288832 Free PMC article.

8

GLI2-Mediated Inflammation in the Tumor Microenvironment.

Han W, Allam SA, Elsawa SF. Han W, et al. Adv Exp Med Biol. 2020;1263:55-65. doi: 10.1007/978-3-030-44518-8_5. Adv Exp Med Biol. 2020. PMID: 32588323 Review.

9

Epigenetic targeting of Waldenström macroglobulinemia cells with BET inhibitors synergizes with BCL2 or histone deacetylase inhibition.

Matissek SJ, Han W, Karbalivand M, Sayed M, Reilly BM, Mallat S, Ghazal SM, Munshi M, Yang G, Treon SP, Walker SR, Elsawa SF. Matissek SJ, et al. Among authors: han w. Epigenomics. 2021 Jan;13(2):129-144. doi: 10.2217/epi-2020-0189. Epub 2020 Dec 24. Epigenomics. 2021. PMID: 33356554 Free PMC article.

10

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling.

Matissek SJ, Karbalivand M, Han W, Boutilier A, Yzar-Garcia E, Kehoe LL, Gardner DS, Hage A, Fleck K, Jeffers V, Rajsbaum R, Elsawa SF. Matissek SJ, et al. Among authors: han w. Oncotarget. 2023 May 12;14:448. doi: 10.18632/oncotarget.28430. Oncotarget. 2023. PMID: 37171385 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,626 results

Search Page

Filters